Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure have?
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure has 166 citations in the OpenAlex counts ScholarIQ stores.
When was Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure published?
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure has 2021 year in the ScholarIQ index.
What is the open-access status of Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure?
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure has hybrid oa status in the ScholarIQ index.
What is the DOI of Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure?
The DOI for Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure is on the source record.
What is the PMID of Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure?
The PMID for Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure is on the source record.
What is the OpenAlex record for Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure?
The OpenAlex for Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure is on the source record.